Cravath partner and Leader of the Firm’s International Practice Mark I. Greene was featured as a “Dealmaker of the Year” in the April issue of The American Lawyer. Mark is one of 10 lawyers in the country selected by the publication for their work on last year’s most innovative and interesting corporate transactions.
The feature article highlighted his role in advising Mylan in its $5.3 billion inversion acquisition of Abbott’s generic drug business, its successful takeover defense against Teva’s $40 billion hostile bid and its $35 billion offer for Perrigo. Mark is described by Mylan executive chairman and former CEO Robert Coury as a “trusted adviser who doesn’t tell us what he thinks we want to hear, but rather what we need to hear.”
